Inhibition of non MHC-restricted cytotoxicity of human NK cells and a CD8+αβ T cell clone by MHC class I cross-linking

Inmunologia

Volumn 23, Issue 3, 2004, Pages 284-292

  Aparicio Alonso, Pedro ^a,c   Rubio Pedraza, G ^b   Caparros Cayuela E ^a   Ferez X ^a   Beltran De Heredia A ^a   Hernandez Caselles T ^a   Carpio Munoz E ^a   Marti Perez S ^b   Aguado Vidal, E ^a   García Peñarrubia, Pilar ^a,c  

^a Unit of Pharmacology   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

Cytotoxicity; Human MHC class I molecules; Inhibitory receptors; Rafts colocalization

Indexed keywords

CD8ALPHA ANTIGEN; GAMMA INTERFERON; LYMPHOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; APOPTOSIS; CELLULAR DISTRIBUTION; CROSS REACTION; CYTOTOXIC LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; ENDOTHELIUM CELL; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MEMBRANE; LYMPHOCYTOTOXICITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MICROTUBULE ORGANIZING CENTER; MITOSIS INHIBITION; NATURAL KILLER CELL; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TARGET CELL DESTRUCTION;

EID: 19944426900     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Colucci F, Di Santo JP, Leibson, PJ. Natural killer cell activation in mice and men: different triggers for similar weapons. Nat Immunol 2002; 3: 807-813.
2. Trowsdale J. Genetic and functional relationships between MHC and NK receptors. Immunity 2001; 15: 363-374.
3. Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R, Moretta A. Human Natural Killer cells: their origin, receptors and function. Eur J Immunol 2002; 32: 1205-1211.
4. Larder LL. NK cell receptors. Annu Rev Immunol 1998;16:359-393.
5. Bonneville M, Lang F. CD8: from coreceptor to comodulator. Nat Immunol. 2002; 3: 12-14.
6. Bjorkman PJ, Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1999; 59: 253-288.
7. Turco MC, Romano MF, Lamberti A, Petrella A, Bisogni R, Sun SC, et al. Induction of nuclear factor kappa B/Rel nuclear activity in human peripheral blood T lymphocytes by anti-HLA class I monoclonal antibodies. Tissue Antigens 1997; 50: 1-7.
8. Mittler RS, Fifer CA, Burbach P, Edinger K, Kiener PA. Evidence for a new HLA determinant that causes T cell activation without costimulation. J Immunol 1990; 145: 794-803.
9. Bregenholt S, Ropke M, Skov S, Claesson MH. Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions. J Immunol 1996; 157: 993-999.
10. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252: 1424-1427.
11. Braun M. The T-cell receptor: just another hypothesis. Cell Immunol 1976; 25: 1-7.
12. Amirayan N, Vernet C, Machy P. Class I-specific antibodies inhibit proliferation in primary but not secondary mouse T cell responses. J Immunol 1992; 148: 1971-1978.
13. Houlden BA, Widacki SM, Bluestone JA. Signal transduction through class IMHC by a monoclonal antibody that detects multiple murine and human class I molecules. J Immunol 1991; 146: 425-430.
14. Matsuoka S, Tsurui H, Abe M, Terashima K, Nakamura K, Hamano Y, et al. A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model. J Exp Med 2003; 198: 497-503.
15. Smith DM, Bluestone JA, Jeyarajah DR, Newberg MH, Engelhard VH, Thistlethwaite JR Jr, et al. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol 1994; 153: 1054-1067.
16. Skov S, Nielsen M, Bregenholt S, Odum N, Claesson MH. Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells. Blood 1998; 91: 3566-3573.
17. Skov S, Bregenholt S, Claesson MH. MHC class I ligation of human T cells activates the ZAP70 and p561ck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis. J Immunol 1997; 158: 3189-3196.
18. Pedersen AE, Jacoby BF, Skov S, Claesson MH. MHC class I is functionally associated with antigen receptors in human T and B lymphomas. Cell Immunol 1996; 173: 295-302.
19. Skov S, Klausen P, Claesson MH. Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis. J Cell Biol 1997; 139: 1523-1531.
20. Ruhwald M, Pedersen AE, Claesson MH. MHC class I cross-talk with CD2 and CD28 induces specific intracellular signalling and leads to growth retardation and apoptosis via a p56(lck)-dependent mechanism. Exp Clin Immunogenet 1999; 16: 199-211.
21. Jin YP, Singh RP, Du ZY, Rajasekaran AK, Rozengurt E, Reed EF. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol 2002; 168: 5415-5423.
22. Jewett A. Activation of c-Jun N-terminal kinase in the absence of NFkappaB function prior to induction of NK cell death triggered by a combination of anti-class I and anti-CD16 antibodies. Hum Immunol 2001; 62: 320-331.
23. Petersson MG, Gronberg A, Kiessling R, Perm MT. Engagement of MHC class I proteins on natural killer cells inhibits their killing capacity. Scand J Immunol 1995; 42: 34-38.
24. Rubio G, Ferez X, Sanchez-Campillo M, Galvez J, Marti S, Verdu R, et al. Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines. J Leukoc Biol 2004; 76: 116-124.
25. Caparros E, de Heredia AB, Carpio E, Sancho D, Aguado E, Aparicio P. Aggregation of MHC class I molecules on a CD8+ alphabeta T cell clone specifically inhibits non-antigen-specific lysis of target cells. Eur J Immunol 2004; 34: 47-55.
26. Garcia P, Llano M, de Heredia AB, Willberg CB, Caparros E, Aparicio P, et al. Human T cell receptor-mediated recognition of HLA-E. Eur J Immunol 2002; 32: 936-944.
27. Gur H, el-Zaatari F, Geppert TD, Wacholtz MC, Taurog JD, Lipsky PE. Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction. J Exp Med 1990; 172: 1267-1270.
28. Wagner N, Engel P, Vega M, Tedder TF. Ligation of MHC class I and class II molecules can lead to heterologous desensitization of signal transduction pathways that regulate homotypic adhesion in human lymphocytes. J Immunol 1994; 152: 5275-5287.
29. Geppert TD, Lipsky PE. Association of various T cell-surface molecules with the cytoskeleton. Effect of cross-linking and activation. J Immunol 1991; 146: 3298-3305.
30. Vereb G, Matko J, Vamosi G, Ibrahim SM, Magyar E, Varga S, et al. Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts. Proc Natl Acad Sci USA. 2000; 97: 6013-6018.
31. Damjanovich S, Matyus L, Damjanovich L, Bene L, Jenei A, Matko J, et al. Does mosaicism of the plasma membrane at molecular and higher hierarchical levels in human lymphocytes carry information on the immediate history of cells? Immunol Lett 2002; 82: 93-99.
32. Lou Z, Jevremovic D, Billadeau DD, Leibson PJ. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J Exp Med 2000; 191: 347-54.
33. Sancho D, Nieto M, Llano M, Rodriguez-Fernandez JL, Tejedor R, Avraham S, et al. The tyrosine kinase PYK-2/RAFTK regulates natural killer (NK) cell cytotoxic response, and is translocated and activated upon specific target cell recognition and killing. J Cell Biol 2000; 149: 1249-1262.
34. Kuhne MR, Lin J, Yablonski D, Mollenauer MN, Ehrlich LI, Huppa J, et al. Linker for activation of T cells, zeta-associated protein-70, and Src homology 2 domain-containing leukocyte protein-76 are required for TCR-induced microtubule-organizing center polarization. J Immunol 2003; 171: 860-866.
35. Bergenthal A, Hofmann M, Heeg K. Self-veto mechanism of CD8+ cytotoxic effector T cells. Peptide-induced paralysis affects the peptide-MHC-recognizing cytotoxic T lymphocytes and is independent of Fas/Fas ligand interactions. Eur J Immunol 1998; 28: 1911-1922.
36. Vyas YM, Mehta KM, Morgan M, Maniar H, Butros L, Jung S, et al. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J Immunol 2001; 167: 4358-4367.
37. Doucey MA, Scarpellino L, Zimmer J, Guillaume P, Luescher IF, Bron C, et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition. Nat Immunol 2004; 5: 328-336.
38. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001; 19: 291-330.
39. McMahon CW, Raulet DH. Expression and function of NK cell receptors in CD8+ T cells. Curr Opin Immunol 2001; 13: 465-470.
40. Freitas AA, Rocha B. Population biology of lymphocytes: the flight for survival. Annu Rev Immunol 2000; 18: 83-111.
41. Ronchese F, Hermans IF. Killing of dendritic cells: a life cut short or a purposeful death? J Exp Med 2001; 194: F23-F26.
42. Wong P, Pamer EG. Feedback regulation of pathogen-specific T cell priming. Immunity 2003; 18: 499-511.
43. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol 2004; 25: 47-52.
44. Ferlazzo G, Morandi B, D'Agostino A, Meazza R, Melioli G, Moretta A, et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 2003; 33: 306-313.
45. Xie J, Wang Y, Freeman ME 3rd, Barlogie B, Yi Q. Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells. Blood 2003; 101: 4005-4012.
46. Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol 2003; 21: 29-70.
47. Kavanagh DG, Koszinowski UH, Hill AB. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class IMHC at the cell surface and in a pre-Golgi compartment. J Immunol 2001; 167: 3894-3902.
48. Odeberg J, Cerboni C, Browne H, Karre K, Moller E, Carbone E, Soderberg-Naucler C. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol 2002; 55: 149-161.
49. George JF, Thomas JM. The molecular mechanisms of veto mediated regulation of alloresponsiveness. J Mol Med 1999; 77: 519-526.
50. Reich-Zeliger S, Zhao Y, Krauthgamer R, Bachar-Lustig E, Reisner Y. Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity 2000; 13: 507-515.